Suppressor of cytokine signaling (SOCS) 1 is a key negative regulator of interferon (IFN), interleukin (IL)12, and IL-2 family cytokine signaling through inhibition of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. To investigate the temporal induction of SOCS1 in response to cytokine in live cells and its selective regulation of signaling pathways, we generated a mouse expressing a Halo-tag-SOCS1 fusion protein (Halo-SOCS1) under control of the endogenous Socs1 promoter. Homozygous Halo-SOCS1 mice (Halo-Socs1KI/KI) were viable with minor T cell abnormalities, most likely due to enhanced Halo-SOCS1 expression in thymocytes compared with the untagged protein. IFNγ and IL-4 induced Halo-SOCS1 expression in macrophages derived from Halo-Socs1KI/KI mice, and a critical level of SOCS1 expression was required for inhibition of both IFNγ and granulocyte macrophage-colony stimulating factor (GM-CSF)-driven JAK-STAT signaling. In contrast, IFNγ priming to induce SOCS1 did not cross-regulate IL-4 signaling. This study indicates that while SOCS1 expression needs to exceed a critical threshold to inhibit IFNγ signaling, its selective regulation of cytokine signaling results from an as yet undetermined, level of regulatory control.
Get full access to this article
View all access options for this article.
References
1.
AlexanderWS, StarrR, FennerJE, et al.SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell, 1999; 98(5):597–608; doi: 10.1016/s0092-8674(00)80047-1
2.
AmorimA, De FeoD, FriebelE, et al.IFNγ and GM-CSF control complementary differentiation programs in the monocyte-to-phagocyte transition during neuroinflammation. Nat Immunol, 2022; 23(2):217–228; doi: 10.1038/s41590-021-01117-7
3.
BabonJJ, McManusEJ, YaoS, et al.The structure of SOCS3 reveals the basis of the extended sh2 domain function and identifies an unstructured insertion that regulates stability. Mol Cell, 2006; 22(2):205–216; doi: 10.1016/j.molcel.2006.03.024
4.
BeckJ, RondotP, CatinotL, et al.Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurol Scand, 1988; 78(4):318–323; doi: 10.1111/j.1600-0404.1988.tb03663.x
BidgoodGM, KeatingN, DoggettK, et al.SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity. Front Immunol, 2024; 15:1419951; doi: 10.3389/fimmu.2024.1419951
8.
BullockAN, DebreczeniJÉ, EdwardsAM, et al.Crystal structure of the SOCS2–elongin C–elongin B complex defines a prototypical SOCS box ubiquitin ligase. Proc Natl Acad Sci U S A, 2006; 103(20):7637–7642; doi: 10.1073/pnas.0601638103
9.
BundaS, KommarajuK, HeirP, et al.SOCS-1 mediates ubiquitylation and degradation of GM-CSF receptor. PLoS One, 2013; 8(9):e76370; doi: 10.1371/journal.pone.0076370
10.
ChongMM, CornishAL, DarwicheR, et al.Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity, 2003; 18(4):475–487; doi: 10.1016/s1074-7613(03)00078-5
11.
CroomHA, IzonDJ, ChongMM, et al.Perturbed thymopoiesis in vitro in the absence of suppressor of cytokine signalling 1 and 3. Mol Immunol, 2008; 45(10):2888–2896; doi: 10.1016/j.molimm.2008.01.024
12.
DaltonDK, Pitts-MeekS, KeshavS, et al.Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science, 1993; 259(5102):1739–1742; doi: 10.1126/science.8456300
13.
DaveyGM, StarrR, CornishAL, et al.SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential. J Exp Med, 2005; 202(8):1099–1108; doi: 10.1084/jem.20050003
14.
DickensheetsH, VazquezN, SheikhF, et al.Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling. Genes Immun, 2007; 8(1):21–27; doi: 10.1038/sj.gene.6364352
15.
DoggettK, KeatingN, DehkhodaF, et al.The SOCS1 KIR and SH2 domain are both required for suppression of cytokine signaling in vivo. Cytokine, 2023; 165:156167; doi: 10.1016/j.cyto.2023.156167
16.
DuY, BrodeurKE, HsuE, et al.In cis “benign” SOCS1 variants linked to enhanced interferon signaling and autoimmunity. J Autoimmun, 2023; 140:103119; doi: 10.1016/j.jaut.2023.103119
17.
EndoTA, MasuharaM, YokouchiM, et al.A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 1997; 387(6636):921–924; doi: 10.1038/43213
18.
EylesJL, MetcalfD, GrusbyMJ, et al.Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1. J Biol Chem, 2002; 277(46):43735–43740; doi: 10.1074/jbc.M208586200
19.
FennerJE, StarrR, CornishAL, et al.Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol, 2006; 7(1):33–39; doi: 10.1038/ni1287
20.
FujimotoM, NakaT, NakagawaR, et al.Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice. J Immunol, 2000; 165(4):1799–1806; doi: 10.4049/jimmunol.165.4.1799
21.
GruberC, LeeA, ButaS, et al.IL4Rα and IL17A blockade rescue autoinflammation in SOCS1 haploinsufficiency. J Clin Immunol, 2023; 44(1):36; doi: 10.1007/s10875-023-01635-z
22.
HadjadjJ, CastroCN, TusseauM, et al.Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun, 2020; 11(1):5341; doi: 10.1038/s41467-020-18925-4
23.
KamuraT, MaenakaK, KotoshibaS, et al.VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev, 2004; 18(24):3055–3065; doi: 10.1101/gad.1252404
24.
KamuraT, SatoS, HaqueD, et al.The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev, 1998; 12(24):3872–3881; doi: 10.1101/gad.12.24.3872
25.
KörholzJ, GabrielyanA, SowerbyJM, et al.One gene, many facets: multiple immune pathway dysregulation in SOCS1 haploinsufficiency. Front Immunol, 2021; 12:680334; doi: 10.3389/fimmu.2021.680334
26.
KuehAJ, PalM, TaiL, et al.An update on using CRISPR/Cas9 in the one-cell stage mouse embryo for generating complex mutant alleles. Cell Death Differ, 2017; 24(10):1821–1822; doi: 10.1038/cdd.2017.122
27.
LeePY, PlattCD, WeeksS, et al.Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol, 2020; 146(5):1194–1200.e1.191; doi: 10.1016/j.jaci.2020.07.033
28.
LiauNPD, LaktyushinA, LucetIS, et al.The molecular basis of JAK/STAT inhibition by SOCS1. Nat Commun, 2018; 9(1):1558; doi: 10.1038/s41467-018-04013-1
29.
LiuS, YangW, LiY, et al.Fetal bovine serum, an important factor affecting the reproducibility of cell experiments. Sci Rep, 2023; 13(1):1942; doi: 10.1038/s41598-023-29060-7
30.
LosGV, EncellLP, McDougallMG, et al.HaloTag: A novel protein labeling technology for cell imaging and protein analysis. ACS Chem Biol, 2008; 3(6):373–382; doi: 10.1021/cb800025k
31.
LosmanJA, ChenXP, HiltonD, et al.Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J Immunol, 1999; 162(7):3770–3774.
32.
LouisC, Souza-Fonseca-GuimaraesF, YangY, et al.NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS. J Exp Med, 2020; 217(5); doi: 10.1084/jem.20191421
33.
MarineJ-C, TophamDJ, McKayC, et al.SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell, 1999; 98(5):609–616; doi: 10.1016/S0092-8674(00)80048-3
34.
MetcalfD, AlexanderWS, ElefantyAG, et al.Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1. Leukemia, 1999; 13(6):926–934; doi: 10.1038/sj.leu.2401440
35.
MichniackiTF, WalkovichK, DeMeyerL, et al.SOCS1 Haploinsufficiency presenting as severe enthesitis, bone marrow hypocellularity, and refractory thrombocytopenia in a pediatric patient with subsequent response to JAK inhibition. J Clin Immunol, 2022; 42(8):1766–1777; doi: 10.1007/s10875-022-01346-x
36.
MorrisR, KershawNJ, BabonJJ. The molecular details of cytokine signaling via the JAK/STAT pathway. Protein Sci, 2018; 27(12):1984–2009; doi: 10.1002/pro.3519
37.
MuiAL, WakaoH, O’FarrellAM, et al.Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. Embo J, 1995; 14(6):1166–1175; doi: 10.1002/j.1460-2075.1995.tb07100.x
38.
NakaT, MatsumotoT, NarazakiM, et al.Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci U S A, 1998; 95(26):15577–15582; doi: 10.1073/pnas.95.26.15577
39.
NakaT, TsutsuiH, FujimotoM, et al.SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity, 2001; 14(5):535–545; doi: 10.1016/s1074-7613(01)00132-7
40.
NicholsonSE, WillsonTA, FarleyA, et al.Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. Embo J, 1999; 18(2):375–385; doi: 10.1093/emboj/18.2.375
41.
PiganisRA, De WeerdNA, GouldJA, et al.Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J Biol Chem, 2011; 286(39):33811–33818; doi: 10.1074/jbc.M111.270207
42.
PiperC, PesenackerAM, BendingD, et al.T cell expression of granulocyte-macrophage colony-stimulating factor in juvenile arthritis is contingent upon Th17 plasticity. Arthritis Rheumatol, 2014; 66(7):1955–1960; doi: 10.1002/art.38647
43.
QuelleFW, SatoN, WitthuhnBA, et al.JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol, 1994; 14(7):4335–4341; doi: 10.1128/mcb.14.7.4335-4341.1994
44.
ReynoldsG, GibbonJR, PrattAG, et al.Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis. Ann Rheum Dis, 2016; 75(5):899–907; doi: 10.1136/annrheumdis-2014-206578
45.
SasakiA, YasukawaH, SuzukiA, et al.Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells, 1999; 4(6):339–351; doi: 10.1046/j.1365-2443.1999.00263.x
46.
SporriB, KovanenPE, SasakiA, et al.JAB/SOCS1/SSI-1 is an interleukin-2–induced inhibitor of IL-2 signaling. Blood, 2001; 97(1):221–226; doi: 10.1182/blood.v97.1.221
47.
StarrR, MetcalfD, ElefantyAG, et al.Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S A, 1998; 95(24):14395–14399; doi: 10.1073/pnas.95.24.14395
48.
StarrR, WillsonTA, VineyEM, et al.A family of cytokine-inducible inhibitors of signalling. Nature, 1997; 387(6636):917–921; doi: 10.1038/43206
49.
ThaventhiranJED, Lango AllenH, BurrenOS, et al;Primary Immunodeficiency Consortium for the NIHR Bioresource. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 2020; 583(7814):90–95; doi: 10.1038/s41586-020-2265-1
50.
UshikiT, HuntingtonND, GlaserSP, et al.Rapid inflammation in mice lacking both SOCS1 and SOCS3 in hematopoietic cells. PLoS One, 2016; 11(9):e0162111; doi: 10.1371/journal.pone.0162111
51.
YasukawaH, MisawaH, SakamotoH, et al.The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. Embo J, 1999; 18(5):1309–1320; doi: 10.1093/emboj/18.5.1309
52.
ZadjaliF, PikeAC, VesterlundM, et al.Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase. J Biol Chem, 2011; 286(1):480–490; doi: 10.1074/jbc.M110.173526
53.
ZhangJ-G, FarleyA, NicholsonSE, et al.The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A, 1999; 96(5):2071–2076; doi: 10.1073/pnas.96.5.2071
